- Global Pharma News & Resources

Press Releases

Date Title Company
27-May-2022 Prefilled Formalin Vials Market Slated to Increase at a CAGR of 4.1% to Reach Valuation of US$ 515.8 Million by 2028 MARKITWIRED
27-May-2022 Cardiac Biomarker Diagnostic Test Kits Market Expected to Expand at 5.1% CAGR From 2022 to 2028 MARKITWIRED
27-May-2022 Dry Powder Inhaler Market Set to Experience Significant Growth of 4.6% CAGR by The End of 2031 MARKITWIRED
27-May-2022 Anti-microbial/Anti-fungal Tests Market Projected to Witness a Higher CAGR of 5.6% From 2017-2027 MARKITWIRED
27-May-2022 Laser Therapy Devices Market Growing at a CAGR of 4% by The End of 2031 MARKITWIRED
27-May-2022 Chromatography Resin Market to Expand at a Steady Growth Rate of Around 6.90% CAGR by The End of 2031 MARKITWIRED
27-May-2022 Thyroid Function Test Market Will Rise at a CAGR of 3.2% by The End of 2025 MARKITWIRED
27-May-2022 Small-Molecule Injectable Market Expected to Reach Total US$ 112.9 Billion by 2031 MARKITWIRED
27-May-2022 Vacuum Blood Collection Devices Market Expected to Register Growth at 6.3% CAGR at The Forecast Period by 2031 MARKITWIRED
27-May-2022 Sleep Apnea Diagnostic Systems Market Will Rise CAGR of 5.73% by The End of 2031 MARKITWIRED
27-May-2022 Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA Cosmo Pharmaceuticals N.V.
27-May-2022 Immutep announces publication of TACTI-002 and TACTI-003 abstracts at ASCO 2022 Immutep
27-May-2022 Medicines Patent Pool, ViiV Healthcare enter negotiations over voluntary licensing of cabotegravir Long-Acting for HIV pre-exposure prophylaxis ViiV Healthcare
27-May-2022 First patients dosed in IRIS Phase III trial evaluating Saphnelo in lupus nephritis PUBLISHED27 May 2022 AstraZeneca
27-May-2022 Almirall initiates decentralised procedure in Europe for the treatment of mild to moderate fungal nail infection with efinaconazole Almirall
27-May-2022 Oxford BioTherapeutics to Present Initial Positive Data from Phase I Trial at ASCO 2022 Oxford BioTherapeutics
27-May-2022 NovalGen announces compelling data from the Phase 1/2 Study of NVG-111 at the ASCO Annual Meeting NovalGen
27-May-2022 Transgene to Present Updated Positive Preliminary Data from the Phase I Clinical Trials with TG4050 (myvac® platform) at ASCO 2022 Transgene
27-May-2022 Enterome to present three abstracts on its novel OncoMimics™ cancer immunotherapies at ASCO 2022 Enterome
27-May-2022 4D pharma presents trial in progress poster on the Phase II Study of MRx0518 in combination with BAVENCIO(R) in patients with unresectable locally advanced or metastatic urothelial carcinoma at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting 4D pharma plc